To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China.
About This Bill
Committee
Latest Action · September 24, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The CLAWS Act of 2024 requires the Office of Management and Budget to direct all federal agencies to report annually on biomedical research funded by the United States government that is conducted in China or by Chinese entities. The reporting requirement applies to research funded through grants, contracts, and other assistance agreements and must include detailed information about each project, such as its purpose, whether it involves dangerous pathogens or dual-use research, the specific locations where work occurs, and any connections to the Chinese government or military. Federal agencies must begin submitting this information within one year of the law's enactment, and the reports will include project costs, timelines, contractors involved, and any documented security or compliance issues. The bill affects all executive agencies and independent regulatory agencies that fund biomedical research, as well as any organizations receiving such funding to conduct research in China.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.